These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3519560

  • 1. Mechanisms of synergistic interactions between amphotericin B and flucytosine.
    Beggs WH.
    J Antimicrob Chemother; 1986 Apr; 17(4):402-4. PubMed ID: 3519560
    [No Abstract] [Full Text] [Related]

  • 2. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH, Liushih RN, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD, Huston AC.
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ, DeLallo VC, Lewis RE, Ernst EJ, Klepser ME.
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [Abstract] [Full Text] [Related]

  • 5. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS, Bartlett MS, Smith JW.
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [Abstract] [Full Text] [Related]

  • 6. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G, Kobayashi GS.
    J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
    [No Abstract] [Full Text] [Related]

  • 7. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S, Wagner G, Espinel-Ingroff E, Davis BA.
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [Abstract] [Full Text] [Related]

  • 8. Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.
    Schwarz P, Janbon G, Dromer F, Lortholary O, Dannaoui E.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):383-5. PubMed ID: 17043122
    [Abstract] [Full Text] [Related]

  • 9. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
    Hamilton JD, Elliott DM.
    J Infect Dis; 1975 Feb; 131(2):129-37. PubMed ID: 1090685
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo studies on synergistic antifungal activity.
    Shadomy S.
    Contrib Microbiol Immunol; 1977 Feb; 4():147-57. PubMed ID: 342191
    [No Abstract] [Full Text] [Related]

  • 11. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A.
    Chemotherapy; 1978 Feb; 24(1):2-16. PubMed ID: 338264
    [Abstract] [Full Text] [Related]

  • 12. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ, Edwards JE, Guze LB.
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [Abstract] [Full Text] [Related]

  • 13. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
    Hamra LK, Pankiewicz IJ.
    Med J Aust; 1977 Nov 26; 2(22):749-50. PubMed ID: 347230
    [Abstract] [Full Text] [Related]

  • 14. Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
    Craven PC, Graybill JR.
    J Infect Dis; 1984 Apr 26; 149(4):584-90. PubMed ID: 6327836
    [Abstract] [Full Text] [Related]

  • 15. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
    Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31988099
    [Abstract] [Full Text] [Related]

  • 16. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH, Andrews FA, Sarosi GA.
    Res Commun Chem Pathol Pharmacol; 1977 Mar 24; 16(3):557-60. PubMed ID: 322227
    [No Abstract] [Full Text] [Related]

  • 17. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH, Sarosi GA.
    Chemotherapy; 1982 Mar 24; 28(5):341-4. PubMed ID: 6754278
    [Abstract] [Full Text] [Related]

  • 18. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W.
    Dermatol Monatsschr; 1982 May 24; 168(5):317-20. PubMed ID: 7049776
    [No Abstract] [Full Text] [Related]

  • 19. [Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi].
    de Resende MA.
    Rev Inst Med Trop Sao Paulo; 1979 May 24; 21(6):344-6. PubMed ID: 550288
    [No Abstract] [Full Text] [Related]

  • 20. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
    Srimuang S, Prariyachatigul C, Chaiprasert A, Rungsipanuratn W, Tanphaichitra D.
    J Med Assoc Thai; 2000 Jan 24; 83(1):57-60. PubMed ID: 10710870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.